Episode Details
Back to EpisodesFever Breaking For Momentum Stocks… And Sarepta Surges After FDA Approval 6/21/24
Published 1 year, 8 months ago
Description
Has the fever broken for the high momentum stocks? Nvidia running out of steam this week, as some other high fliers also pull back. Is this just a bump in the road or the beginning of a summer slowdown? Plus Sarepta’s big surge. The biotech company getting expanded approval from the FDA for its muscular dystrophy drug. What the CEO says is next for the company.